Quince Therapeutics, Inc. 8-K

What Happened
Quince Therapeutics, Inc. (QNCX) filed a Form 8‑K on February 2, 2026 (Item 5.02) reporting that five members of its Board of Directors — Rajiv Patni, Luca Benatti, Margi McLoughlin, Una Ryan, and June Bray — tendered their resignations effective January 30, 2026. The filing states the resignations were not the result of any disagreement with the company regarding its operations, policies, or practices.

Key Details

• Filing: Form 8‑K filed February 2, 2026 (Item 5.02 — Departure/Election of Directors).
• Effective date of resignations: January 30, 2026.
• Directors who resigned: Rajiv Patni, Luca Benatti, Margi McLoughlin, Una Ryan, June Bray.
• Company ticker: QNCX. Resignations reported as not due to any disagreement with the company.

Why It Matters
Board departures can affect corporate governance and may trigger changes in board composition, committee membership, or succession planning. For investors, this is a governance event to watch; the company may disclose follow‑on actions (appointments or board restructuring) in subsequent filings. There is no indication in this 8‑K of disputes or operational disagreements tied to the resignations.